ʻO ka maʻi ʻaʻai ʻana o ka maʻi pūpū liʻiliʻi liʻiliʻi (NSCLC)-02

Ua hōʻike mua ʻia kahi maʻi kāne he 82 makahiki i ka hoʻomaka ʻana o Malaki 2023 me ka nawaliwali ākea holomua, ka pau ʻana o ka ʻai, a me ka pohō kaumaha ma kahi o 5 kilokani. Ma ke komo ʻana, ua hana ʻia nā hoʻokolohua kikoʻī. Ua hōʻike ʻia kahi hōʻike hōʻike umauma CT i nā nodule he nui ma nā māmā ʻelua, ʻo ka nui loa ma kahi o 2.5 cm. ʻO ka nodule nui loa ma ka ʻāpana apical o ka lobe lalo ʻākau a me ka nodule nui loa ma ka ʻaoʻao hope o ka lobe hema hema ʻelua, ʻaʻole ʻike ʻia nā palena. Ma hope o ka biopsy o ka umauma a me ka hoʻokolokolo pathological, ua hōʻoia ʻia ka ʻike o ka maʻi maʻi ʻaʻai liʻiliʻi liʻiliʻi (NSCLC), me ka adenocarcinoma aia ma ka ʻaoʻao hope o ka ʻaoʻao hema hema a me ka ʻāpana apical o ka lobe lalo ʻākau.

Ua loaʻa i ka mea maʻi kahi hoʻoponopono immunotherapy cell NK. Ma hope o ka malama mua o ka lapaʻau ʻana, ʻaʻole i hōʻike ʻia kahi hoʻokolohua hahai ʻana i ka loli nui o ka nui o nā nodules māmā, akā ua hoʻomaikaʻi ʻia nā hōʻailona holoʻokoʻa o ka mea maʻi, me ka emi ʻana o ka nāwaliwali a me ka hoʻi mālie ʻana o ka ʻai. Ma hope o ka malama ʻelua o ka mālama ʻana, ua hōʻike ʻia kahi hōʻike ʻē aʻe o ka umauma CT i kahi ʻoi aʻe a me ka emi iki ʻana o ka nui o ka nodule ma ka ʻāpana apical o ka ʻaoʻao haʻahaʻa akau, a me ka necrosis hapa me kahi kikoʻī o ka nodule i ka ʻāpana hope o ka lobe luna hema. Ma hope o ke kolu o ka malama o ka mālama ʻana, ua hōʻike ka umauma CT i ka emi ʻana o ka nui o nā nodules ma nā māmā ʻelua, me ka nodule nui loa i kēia manawa ʻaʻole iʻoi aku ma mua o 1.5 knm, kahi absorption o nā ʻeha pulmonary, a ʻike ʻia ka hoʻomaikaʻi maikaʻi.

I ka hōʻuluʻulu ʻana, ua hōʻike ʻo NK cell immunotherapy i ka maikaʻi a me ka hoʻomanawanui ʻana i kēia maʻi kāne 82-makahiki me NSCLC, me ka hōʻemi nui ʻana i nā ʻōpala māmā a me ka hoʻomaikaʻi nui ʻana i ke kūlana holoʻokoʻa o ka mea maʻi. E hoʻomau ka mālama ʻana a me nā hoʻolālā lapaʻau hou e nānā i ka piʻi ʻana o ka maʻi a me nā hopena lapaʻau.